- Home
- PRDO vs IMCR Comparison
PRDO vs IMCR Comparison
Compare PRDO & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRDO
- IMCR
- Stock Information
- Founded
- PRDO 1994
- IMCR 2008
- Country
- PRDO United States
- IMCR United Kingdom
- Employees
- PRDO N/A
- IMCR N/A
- Industry
- PRDO Other Consumer Services
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PRDO Real Estate
- IMCR Health Care
- Exchange
- PRDO Nasdaq
- IMCR Nasdaq
- Market Cap
- PRDO 2.1B
- IMCR 1.7B
- IPO Year
- PRDO N/A
- IMCR 2021
- Fundamental
- Price
- PRDO $28.45
- IMCR $35.17
- Analyst Decision
- PRDO Buy
- IMCR Buy
- Analyst Count
- PRDO 1
- IMCR 10
- Target Price
- PRDO $40.00
- IMCR $58.13
- AVG Volume (30 Days)
- PRDO 687.4K
- IMCR 250.5K
- Earning Date
- PRDO 07-31-2025
- IMCR 08-07-2025
- Dividend Yield
- PRDO 1.82%
- IMCR N/A
- EPS Growth
- PRDO N/A
- IMCR N/A
- EPS
- PRDO 2.25
- IMCR N/A
- Revenue
- PRDO $726,003,000.00
- IMCR $333,581,000.00
- Revenue This Year
- PRDO $24.62
- IMCR $26.82
- Revenue Next Year
- PRDO $3.83
- IMCR $8.15
- P/E Ratio
- PRDO $12.72
- IMCR N/A
- Revenue Growth
- PRDO 6.35
- IMCR 25.75
- 52 Week Low
- PRDO $20.55
- IMCR $23.15
- 52 Week High
- PRDO $34.60
- IMCR $40.88
- Technical
- Relative Strength Index (RSI)
- PRDO 30.32
- IMCR 53.52
- Support Level
- PRDO $28.23
- IMCR $32.20
- Resistance Level
- PRDO $30.05
- IMCR $37.63
- Average True Range (ATR)
- PRDO 0.76
- IMCR 1.21
- MACD
- PRDO -0.15
- IMCR 0.03
- Stochastic Oscillator
- PRDO 6.96
- IMCR 53.90
About PRDO Perdoceo Education Corporation
Perdoceo Education Corp is an American for-profit education company that focuses on quality postsecondary education online to a diverse student population, along with campus-based and blended learning programs. The company's important segments include the American InterContinental University, the University of St. Augustine for Health Sciences, and Colorado Technical University. These universities provide undergraduate, graduate, and doctoral degree programs focusing on business, technology, management, and social services, with the majority of the students enrolled in programs offered fully online. The majority of the company's revenue comes from the Colorado Technical University segment.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.